Bioventus, Inc. (BVS)

NASDAQHealth CareMedical - DevicesSnapshot 2026-09-04

$14.07-2.02%

Close 2026-09-04 · 1-day change

QuarterlyIQ Insights · BVS

Financials

Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.

Income Statement

Period

View

Order

Figures in millions of USD, except per-share and ratios.

	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Revenues
Revenues	581.8	568.1	573.3	512.3	512.1	430.9	321.2
Cost of Revenues	182.4	179.9	185.1	184.2	181.0	128.2	87.6
Gross Profit	399.4	388.2	388.2	328.2	331.1	302.7	233.5
Operating Expenses & Income
Selling, General & Admin	322.5	314.0	340.9	303.9	332.1	254.3	193.1
R&D Expenses	11.6	12.1	13.6	13.4	23.9	19.0	11.2
Operating Income	58.3	54.0	(12.0)	(81.7)	(167.2)	12.1	21.2
Earnings from Continuing Operations
Other Non-Operating Income / Expenses	(19.6)	(28.3)	(37.1)	(39.4)	(21.8)	(2.6)	(5.3)
Asset Writedown	—	—	36.4	78.6	135.0	7.0	0.0
EBT, Incl. Unusual Items	38.6	25.7	(49.1)	(121.1)	(189.0)	9.5	15.9
Income Tax Expense	(22.8)	(1.6)	(5.3)	0.1	(44.4)	(2.0)	1.2
Earnings from Continuing Operations	—	27.3	(43.8)	(121.2)	(144.7)	11.5	14.7
Net Income
Minority Interest	—	—	—	—	(54.7)	(9.8)	(1.7)
Net Income	54.5	22.7	(33.5)	(156.2)	(158.7)	19.4	16.4
Per Share
Basic EPS	0.80	0.34	(0.52)	(2.49)	(2.59)	(0.15)	—
Diluted EPS	0.77	0.33	(0.52)	(2.49)	(2.59)	(0.15)	—
Revenue per Share	8.21	—	—	—	—	—	—
Basic Weighted Avg Shares	67.9	66.6	64.5	62.6	61.4	45.5	—
Diluted Weighted Avg Shares	70.8	68.9	64.5	62.6	61.4	45.5	—
Supplemental
EBITDA	—	59.7	(4.3)	(72.9)	(157.5)	20.4	28.7
EBIT	58.3	54.0	(12.0)	(81.7)	(167.2)	12.1	21.2
Effective Tax Rate	-59.1%	—	—	-0.1%	23.5%	-20.7%	7.5%

Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.